Ca'+ fluxes were examined in HEK 293 cells stably expressing the rat or porcine calcitonin receptors (CIRs
Introduction
Calcitonin (CT) is a 32 amino acid peptide whose most recognised action is inhibition of osteoclastic bone resorption [1, 2] . Receptors for CT (CTR) have also been identified in a number of other tissues including kidney [3] , lymphocytes 141, placenta [51, hepatocytes [6] and discrete regions of the central nervous system [7] . Until recently the major focus of intracellular signalling by CT has been stimulation of adenylate clyclase and the CAMP-dependent protein kinase pathway [8, 9] . However, there is growing evidence of CT-induced increases in cytoplasmic Ca2+
([Ca*+ Ii). For example, it is now clear that in the osteoAbbreviations: sCT, salmon cakitonin; [Ca'+ Ii, intracellular calcium; [Ca*+ I,, extracellular calcium; CTR, calcitonin receptor.
clast, signalling through both CAMP and changes in [Ca2+li concentrations, are important in (X action [lo] . CT apparently causes either no change, or an inhibition of, adenylate cyclase activity in brain tissue [ll] , and there is some evidence that Ca*+ acts as a second messenger in this tissue 112,131. Likewise, in hepatocytes CT-induced adenylate cyclase activity has not been shown but CT, even at very low concentrations, is capable of increasing [Ca*+], levels [14] . In LLCPK, pig kidney cells, CT can, in a cell cycle-dependent manner, induce either CAMP or [Ca2+li changes [151. The recent cloning of Cl% of pig [16] , human [17] and rat [Ml origin identifies them as belonging to a new subclass of 7-transmembrane domain (7TIvID) G-protein coupled receptors which includes the receptors for parathyroid hormone, secretin, vasoactive intestinal polypeptide and glucagon-like peptide [19] . Expression in a variety of cell types has conclusively shown that the cloned CTR is capable of signalling through both CAMP and Ca*+ second messenger systems [20, 21] . CT-induced Ca*+ changes in CT target tissues are potentially of great importance since, in general, excursions of [Ca2+li are linked to many key cellular events [22] .
It is now widely recognised that most cells employ intracellular and extracellular sources of Ca*+ in cell signalling. Many agonists which activate plasma membrane receptors stimulate rapid increases in [Ca2+li levels from intracellular stores. In the presence of extracellular Ca*+ ([Ca*'],>, this induces an inflow of Ca*+ into the cell. This general phenomenon of agonist-induced Ca*+ inflow to cells has been the subject of intense study. Although it appears that the details differ between agonists and cell types, there is good evidence that agonist-induced emptying of [Ca2+li stores secondarily leads to opening of some, as yet undefined, plasma membrane Ca*+ channels [23] . Termed the 'capacitative model' [23] , this was recently refined with the discovery of several soluble mediators which potentially link [Ca2+li store depletion to influx of [Ca*+l, [24, 25] .
A recent report showed that cells transfected with the human CTR were rendered sensitive to changes in [Ca*+ I, levels, responding by increased [Ca2+liconcentration [26] . The CTR was therefore described by those workers as a 'calcium sensor'. These results were interesting in terms of a general understanding of the function of the CTR but were particularly so with respect to its function in bone-resorbing osteoclasts, which are exposed to high [Ca*+], concentrations [27] . Interestingly, there is an early report which showed that in unfractionated bone cells from embryonic rat calvariae, there was transfer of Ca*+ from the medium into cells which was dependent on the [Ca*+ I, and which was enhanced by CT [28] . It is known that the osteoclast is also able to sense changes in [Ca*+], and to respond by increasing [Ca2+li, a function believed to be mediated by a cell surface Ca*+ receptor [29] . It is intriguing to speculate as to whether this receptor is itself the CTR or whether the function of a distinct Ca*+ receptor is modulated by the CTR in osteoclasts. A Ca*+ receptor was recently cloned from parathyroid cells [30] and like the CTR, was shown to belong to the 7 TMD receptor class. Although the osteoclast Ca*+ receptor is apparently different from that of the parathyroid, activation of Ca*+ receptors by Ca2+ in both osteoclasts [31] and parathyroid cells [30, 32] results in release of Ca *+ from intracellular storage organelles, which in turn activates capacitative influx of [Ca'+],.
We were interested to enquire whether the CTR sensitises cells to Ca*+ by itself acting as a Ca*+ receptor or whether its stimulation of extracellular Ca*+ inflow occurs secondarily to intracellular signalling. We have used HEK 293 cells, in which there is no evidence for the presence of a Ca*+ receptor, stably transfected with cloned rat or porcine CTR and compared CT-mediated Ca*+ inflow with Ca*+ inflow stimulated by thapsigargin. The results suggest that the rat and porcine CTR in HEK 293 cells mediate Ca*+ influx in a manner consistent with capacitative Ca*+ inflow described for several other receptor systems.
Materials and methods

Hormones and chemicals
The porcine CTR (pCTR) cDNA clone 3J8-14-Fl was a gift from Dr H. Lin (Boston, MA, USA). Synthetic salmon calcitonin (sCT) was from Bachem (Torrance, CA, USA). 8-bromoadenosine 3',5'-cyclic monophosphate (&bromo CAMP), thapsigargin and phorbol 12-myristate 13-acetate (PMA) were purchased from the Sigma Chemical Co. (St. Louis, MO). All other chemicals were of reagent grade and obtained from standard suppliers.
Cell culture
Cell lines used in these studies were human embryonic kidney (HEK 293) cells stably transfected with the rat CTR Cla and Clb isoforms [18] , the porcine CTR [16] or the plasmid vector pCDNA-l,, (Invitrogen, San Diego, USA). The preparation and characterisation of these stably transfected cell lines is described elsewhere [33] . Briefly, cells were transfected by the calcium phosphate method and 48 h after transfection G418 was added to the medium and selection maintained for 2 weeks. G418 resistant cells were subcloned by two rounds of limiting dilution. Cloned cells were screened for CTR expression by measurement of 1251-sCT binding. Receptor numbers per cell in the cells selected and used for the studies herein, were approximately: Cla cells, 5 . 10'; Clb cells, 6. 106; porcine CTR-expressing cells, 9 * 106. Cells were maintained at 37°C in a humidified atmosphere with 5% CO, in air, in complete Dulbecco's Modified Eagle's medium (DME, Gibco, Grand Island, NY) containing 5% fetal bovine serum (FBS) (Cytosystems, NSW, Australia), 80 mg/l gentamicin (Delta West, WA, Australia), 1 mg/l minocycline (Sigma, St. Louis, MO), 15 mM Hepes (Gibco) and 200 pg/ml G418.
Intracellular calcium measurement
Intracellular Ca*+ measurements were made in cells in suspension. Cells grown in 75 cm* flasks were changed to phenol red-free DME containing 10% FBS approximately 2 h before experiments. For experiments, the cells were treated briefly with trypsin/EDTA, centrifuged and resuspended in 10 ml assay medium (phenol red-free DME containing 0.1% (w/v) Pentex lipid-free BSA (Miles Scientific, Naperville, IL) and containing u 1.8 mM Ca*+). The cells in suspension were loaded with fura-(Molecular Probes, Eugene, OR) by incubating with 2 PM of the acetoxymethyl ester (dissolved in dimethyl sulfoxide) for 30 min at 37"C/5% CO, as described [34] . The cells were then centrifuged at approx. 500 X g for 5 min and washed once with 10 ml assay medium. The supematant was removed and the pellet resuspended in medium at a concentration of approximately lo6 cells/ml. Fluorescence (emission 505 nm) was mleasured from cells excited at 340 and 380 nm using a Spex Fluorolog 2 spectrofluorimeter. Cells were kept in suspension by gentle stirring and were maintained at 37°C during the course of experiments. Calibration and calculation of intracellular calcium concentration ([Ca" I,) were performed as previously described [351.
Results
Effect of calcitonin a.nd [Ca' '1, on [Ca' 'Ii
Intracellular calcium measurements were made in suspensions of fura-2-loaded cells. Most experiments were carried out using cells stably expressing the Clb isoform of the rat CIR because the high receptor number in these cells resulted in consistent and easily measurable responses. Salmon CT rapidly increased [Ca"], in these cells in a dose-dependent manner, and [Ca"], was sustained above the basal level when cells were incubated in medium containing Ca2+ (Fig. 1A) . In addition, in cells pretreated with sCT, subsequent elevation of the [Ca2+], concentration resulted in a further increase in [Ca2+li (Fig.  1A) . These events were also observed in HEK 293 cells transiently transfected with the Clb CTR (not shown) or stably transfected with the Cla isoform of the rat CTR (not shown) or the porcine CTR (Fig. 1D) .
Increases in [Ca2+], only influenced [Ca2'li when CTR-expressing HEK 293 cells were first exposed to CT (compare Fig. 6A and B) .. Non transfected HEK 293 cells, or cells transfected with the pCDNA-l,, vector only, were unresponsive to CT or to elevation of [Ca2+], concentration, regardless of the order of addition (see Fig. 5 ).
We considered it relevant to simulate physiological conditions so that in the present study the cells were suspended in phenol red-free DME with an ambient [Ca2+], of 1.8 mM. However, in order to compare our results with those achieved in several other systems [26, 36, 37] , some cell suspensions were treated with 4 mM EGTA before testing the effects of SC?' and [Ca2'],. In the presence of chelated [Ca2+],, sCT again induced a rapid increase in [Ca2+li but the sustained phase of this response was absent (Fig. 1B) . This result is consistent with CT induction of Ca2+ release from intracellular stores by an IP,-mediated process, for which there is evidence in the case of the porcine CTR [20, 21] , whlie the sustained phase appears to be due to influx of extracellular Ca2+. Following sCT pretreatment in Ca 2+-deplleted medium, step-wise increases in the [Ca2+], resulted in corresponding increases in [Ca2+li (Fig. 1B) which was not seen when the cells were not first exposed to sCT (Fig. 1C) . 
Comparison of CT-and thapsigargin-stimulated Ca2 ' entry
Thapsigargin is an inhibitor of microsomal Ca2+-ATPase activity and as such has been extremely useful in unravel-bWX1 04) ling the mechanisms of capacitative Ca*+ entry. It is able to mimic the action of many but not all agonists in inducing Ca* + entry by acting directly to discharge the agonist-sensitive intracellular Ca*+ pool [37] . We therefore compared the action of thapsigargin with that of CT in HEK 293 cells expressing the Clb rat CTR. Like sCT, thapsigargin also induced a rapid increase in [Ca2+li which was sustained in the presence of extracellular Ca*+ (compare Fig. 4A and C) but was transient in cell suspensions treated with thapsigargin in the presence of EGTA (Fig.  4E) . In cells treated with thapsigargin there was also a further increase in [Ca2+li in response to an incremental increase in [Ca*'], (Fig. 4C, F) . Since both CT and thapsigargin sensitise cells to extracellular calcium, these results suggest that CT and thapsigargin may act in a similar manner to induce Ca*+ inflow by a capacitative entry mechanism. Thapsigargin-induced Ca*' inflow was not dependent upon the presence of the CTR. HEK 293 cells stably transfected with pCDNA-l,,, alone were also rendered sensitive to [Ca*+], by thapsigargin (Fig. 5B) , although not CT (Fig. 5C ), treatment. Fig. 5A shows that vectortransfected cells did not respond to [Ca*+], without thapsigargin treatment.
Mechanism by which calcitonin mediates [Ca2 '1, effects
Experiments were designed to examine the mechanism of CT-induced Ca *+ influx in HEK 293 cells transfected with the rat Clb ClR isoform. Cells were treated for short (approx. 1 min) or long (up to 30 min) periods with agonists of the CAMP pathway, Sbromo CAMP or forskolin, or the phorbol ester, phorbol 1Zmyristate 13 acetate (PMA) which activates PKC. Neither short (Fig.  6A, D) nor long (not shown) treatment with these agents alone resulted in responsiveness to changes in [Ca*'], in cells not treated with CT. Moreover, none of the treatments significantly modified &T-induced [Ca*+ 1, responses to increased [Ca2+le. The particular examples shown are PMA (Fig. 6C ) or 8-bromo CAMP treatment, the latter added before [Ca*+ 1, elevation (Fig. 6D) , before sCT addition (Fig. 6E) or after sCT and before [Ca2+le elevation (Fig. 6F) . The small (approx. 2-fold) difference in [Ca*+ Ii levels within this experiment were difficult to avoid in experiments run over several hours. However, from results of several such experiments it was concluded that qualitatively neither CAMP pathways, nor those involving activated PKC, were responsible for CT-mediated Ca*+ inflow.
In order to determine the contribution of G proteins in CTR-mediated Ca*+ inflow, it was of interest to determine whether this mechanism is sensitive to pertussis toxin. This was found not to be the case in HEK 293 cells expressing the Clb CTR receptor treated for 16 h with pertussis toxin. Both CT-stimulated [Ca*+l,, and Ca*+ influx due to sub-sequent elevation of [Ca?+le, were essentially identical between control cells (Fig. 4A ) and cells pretreated with pertussis toxin (Fig. 4B) . The same result was obtained in cells pretreated for 30 min (results not shown). In addition, results qualitatively similar to control were obtained with thapsigargin in cells pretreated with pertussis toxin for 30 min (not shown) or 16 .h (Fig. 4D, F> . Activity of the pertussis toxin preparation used was confirmed independently (not shown).
The means by which <:a'+ obtains entry in agonist-induced Ca2+ inflow is not clear, but the ineffectiveness of most inhibitors of voltage-operated calcium channels suggests that these two mechanisms are distinct. For example, receptor-activated Ca2+ entry in hepatocytes is reportedly inhibitable only by high concentrations (100 PM) of the Ca2+ channel blockers vlerapamil and nifedipine [38] , at which concentrations their effects are likely to be nonspecific [39] . These agents inhibit Gtype voltage-operated CaZf channels at concentrations in the range 100 nM [38] . We tested nifedipine at a concentration of 10 PM for blockade of CT or thapsigargin-induced Ca2+ inflow and in neither case was this agent effective whether added first or before [Ca"], elevation (not shown). Since these results are consistent with those in other systems, it therefore appears that in the case of CTR activated calcium influx also, the relevant calcium channels are distinct from voltage-operated channels.
Discussion
We consider that the most likely interpretation of the above results is that the CTR allows cells to respond to increases in [Ca2+], levels secondarily to CT-induced intracellular Ca2 + fluxes rather than by functioning as a Ca2+ sensor per se. This conclusion is based on the similarity between the CT-mediated Ca2+ influx and the Ca2+ influx induced by other agents, for example EGF or vasopressin [36] . Like HEK 293 cells expressing the rat and porcine CTR, responses to extracellular Ca2+ in these other systems also depend on the presence of the receptor ligand. Ligand binding is believed to stimulate emptying of intracellular Cazf pools, an action mimicked by thapsigargin treatment, and this reagent enables HEK 293 cells to respond to [Ca*'], in a very similar fashion to CT treatment.
The results of our mechanistic studies were analogous to previous reports [40, 41] agonists do not affect CAMP levels in hepatocytes, CAMP is a potentially important mediator of agonist-activated Cazf inflow since the action of glucagon to synergistically increase Ca2 + inflow to hepatocytes caused by angiotensin II or vasopressin is CAMP-dependent [21] . Consistent with the lack of effect of CAMP agonists in the present study, Stroop et al. [26] showed that addition of 8-bromo CAMP or forskolin to CTR-naive BHK cells did not result in Ca2+ influx in response to increased [Ca*+],. However, these workers did not report on the same experiment ,in cells expressing the CTR. There is mounting evidence that heterotrimeric GTP binding regulatory proteins (G-proteins) have a role in agonist-induced Ca2+ inflow in several systems [391. It appears that more than one G-protein is involved and that there is heterogeneity between different agonists and cell types. The work of Berven et al. [36] , for example, suggests that vasopressin-stimulated Ca2+ inflow in the hepatocyte requires a G-protein which is relatively insensitive to pertussis toxin, while EGF-stimulated Ca2+ inflow in the same cell is completely inhibited by pertussis toxin, suggesting involvement of a rapidly ADP-ribosylated Gprotein. The recent report of Bird and Putney [36] indicates involvement in mouse lacrimal acinar cells of a G-protein whose activation depends on GTP hydrolysis, rather than GTP binding. Although pertussis toxin was without effect in the present work, it remains possible that G-proteins are involved in the Ca2+ entry mediated by Cl? and thapsigargin in HEK 293 cells, but the results show that such a protein(s) is not a substrate for pertussis toxin ADP ribosylation.
The hypothesis of Stroop et al. [26] was that the human CTR is a calcium sensor, since its expression enabled cells to 'sense' changes in [Ca2+],. If the CTR were in fact acting as a Ca2+ receptor, cells would require the presence of the CTR but not necessarily ligand binding or signalling. This was found to be the case for the human CTR receptor in T47D cells and for some clonal BHK cell lines expressing the human CTR receptor [26] , however responses to [Ca2+], in human CTR-transfected 9B13 cells required preexposure to CT [26] . Likewise, we found that responsiveness to changes in [Ca2+], by HEK 293 cells expressing the rat or porcine CTRs was totally CT dependent. The explanation for the ability of some human CTR-expressing cells to 'sense' extracellular Ca2+ increases, in the absence of CT 1261 is not known. It is possible that high concentrations of receptor in transfected cells sometimes allows a percentage of receptors to couple agonist-independently to phospholipase C (PLC) activation. Agonist-free coupling could also occur in T47D cells, or alternatively these cells may have some other Ca*+ sensing mechanism.
If the CTR is a separate entity from the Ca2+ receptor on cells such as osteoclasts, it will be important to determine the role of each in directing intracellular events in the face of [Ca2+], changes. The CTR is clearly capable of mediating [Ca2+li increases in response to both CT and [Ca2+],. Therefore it will also be important to study the consequences of receptor-mediated intracellular Ca2+ fluxes in CTR-bearing cells which do not appear to respond to CT with a CAMP increase, and also to dissect out the roles of these second messengers in cells in which both pathways are elicited. For example, it has been known for many years that CT can potently inhibit the growth of CTR-bearing cells, an action believed to be mediated by the specific activation of the type II isoenzyme of the CAMP-dependent protein kinase [9] . Recently, several points of intersection for CAMP inhibition of growth factor-stimulated proliferation pathways have been identified [42, 43] . However, recent reports also support a role for Ca2+-activated pathways in growth modulation; depletion of intracellular Ca2+ stores by thapsigargin was implicated in inhibition of cell growth [44] and mitogenesis by thrombin and bradykinin appeared to involve Gq-mediated increases in [Ca2+li [45] . We have found that CT treatment of mouse marrow culture decreases the production of both mononuclear and multinuclear osteoclast-like cells (Ikegame and Findlay, unpublished data). In addition, in mouse bone marrow culture, CT has been found to inhibit the fusion process leading to multinucleate osteoclast formation, while not affecting formation of the tartrate acidresistant phosphatase-positive mononuclear precursors [46] .
It would therefore be of interest to determine whether the interplay between CT and [Ca2'], is important not only in the acute function of actively resorbing osteoclasts in bone, as has been recognised [lo] , but also in the progression of precursors to multinucleated osteoclasts.
